Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground.
Sunshine, Sea, and Season of Birth: MS Incidence in Wales.
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment.
Ultrahigh-Field MRI May Detect Additional Pathology in EAE
Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.
A New MS Journal
Mucocele After Orbital Fracture Repair Masquerading as Optic Neuritis.
Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation.
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
Papers: 5 Dec 2015 - 12 Dec 2015
ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Newly Identified Gait Patterns in Patient With Multiple Sclerosis May Be Related to Push-Off Quality.
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Pediatric Optic Neuritis Prospective Outcomes Study.
Information processing speed in multiple sclerosis: Past, present, and future.
Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Papers: 22 Dec 2015 - 29 Dec 2015
Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK.
Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.
Papers: 24 Jul 2015 - 31 Jul 2015
Psychometric Analyses to Inform Item Reduction and Evaluate Sensitivity of the Early Mobility Impairment Questionnaire for Multiple Sclerosis.
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »